Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
migraine disorders/náusea
El enlace se guarda en el portapapeles.
Página 1 desde 60 resultados
Methods for iontophoretically treating nausea and migraine
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
Migraine is a condition that affects approximately 28 million people in the United States, with females more frequently affected than males (Silberstein, Neurology, 2000 55:754-63). Migraine headache is associated with a painful vasodilation of cranial vessels that typically manifests in
Methods for iontophoretically treating nausea and migraine
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
Migraine is a condition that affects approximately 28 million people in the United States, with females more frequently affected than males (Silberstein, Neurology, 2000 55:754-63). Migraine headache is associated with a painful vasodilation of cranial vessels that typically manifests in
Pharmaceutical compositions for headache, migraine, nausea and emesis
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
Pharmaceutical compositions for headache, migraine, nausea and emesis
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to the use of S-alkylisothiouronium derivatives, including, but not limited to, S-ethylisothiouronium diethylphosphate, for the prevention or treatment of headache, including but not limited to migraine, and for the prevention or treatment of
Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention concerns a coated vaginal device for delivery of anti-migraine and/or anti-nausea drugs and a method for treatment of migraine and nausea. The vaginal device, such as a vaginal tampon, vaginal tampon-like foam or another vaginal device is completely or
Migraine medicine and method for treating same
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods used to alleviate the symptoms and pain associated with an acute migraine attack.
BACKGROUND OF THE INVENTION
An estimated 24 to 26 million Americans--about 18% of women and 6% of men--suffer from migraine
Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods used to alleviate the symptoms and pain associated with acute migraine attack. More particularly, the present invention relates to the use of a nonprescription combination of acetaminophen, aspirin and
Multisymptom migraine combination medication
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
In the United States, more than 37 million people suffer from migraines. Migraines are associated with decreased productivity and have a deleterious effect on quality of life. It is estimated that the total cost of lost productive time due to migraines is 19.6 billion.
Treatment of migraine with morpholine tachykinin receptor antagonists
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
SUMMARY OF THE INVENTION
This invention is concerned with novel compounds represented by structural formula I: ##STR2## wherein R.sup.2, R.sup.3, R.sup.6, R.sup.7, R.sup.8, R.sup.11, R.sup.12, R.sup.13, A, B, p, Y and Z are hereinafter defined.
The invention is also concerned with pharmaceutical
Methods for treating emesis and nausea using optically pure R(+) ondansetron
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
This invention relates to novel compositions of matter containing optically pure R(+) ondansetron. These novel compositions have potent antiemetic activity and are useful in ameliorating the nausea and vomiting otherwise induced by cancer chemotherapeutic agents and
Analgesic composition for treatment of migraine headaches
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
This invention relates to magnesium-based compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the gastric
Analgesic composition for treatment of migraine headaches
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
This invention relates to magnesium-based analgesic compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the
Treatment of migraine, cluster headaches and trigeminal neuralgia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This invention relates to a method of treatment of migraine, cluster headaches and trigeminal neuralgia, radiation or cytotoxic agent induced nausea and vomiting and/or cardiac arrhythmia in mammals, including humans, and to the use of compounds in the preparation of a medicament for the treatment
Five-membered ring systems with bonded imidazolyl ring substituents
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This invention relates to a class of 5-membered heterocyclic compounds having at least one heteroatom, which are useful in the treatment of psychotic disorders (e.g. schizophrenia and mania); anxiety; alcohol or drug withdrawal or dependence; pain; gastric stasis; gastric dysfunction (such as occurs
Benzisoxazole derivatives
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
This invention relates to benzisoxazole derivatives. These compounds have selective 5-HT.sub.4 receptor agonistic activity. The present invention also relates to a pharmaceutical composition, method of treatment and use, comprising the above derivatives for the treatment
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
